3 ms·
I’m curious how long it would take to adapt the mRNA vaccines to the new ones, if there was two changes. I’m assuming it’d have to reach quite a wide infection
by dmix 5y ago
I’m curious how long it would take to adapt the mRNA vaccines to the new ones, if there was two changes. I’m assuming it’d have to reach quite a wide infection rate for them to tag a particular variant + development/manufacturing time.
The other question that comes to mind is if they can package two different variants into one or would they just mix the two and keep building on top of existing ones? Unless the other ones get completely replaced.
- mlyle 5y agoMaking the mRNA in volume is the easy part. They can turn that around extremely quickly-- large prototype quantities in days, and begin ramping sharply in weeks. The hard part is the formulation chemistry and microfluidics and nanoparticles, which don't change based upon variant mix. Of course, the really hard part is approval, but we feel we understand influenza viruses and vaccines enough to have developed an expedited approval process each year. We should be able to do the same for COVID-19.